HEALTH● LOWAug 1 · Aug 1, 2026, 11:00 AM
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
NPR News
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH41m agoUnderstanding Your Milk Options: A Dietitian’s Guide to Choosing the Right MilkVanguard NigeriaHEALTH1h agoLouie Shum’s death: heart disease in Hong Kong and what to do in an emergencySouth China Morning PostHEALTH1h agoFormer CJI Chandrachud urges doctors to prioritise mental health , uphold humanity in patient care at UCMS 55th anniversarylaosnews.net · United StatesHEALTH1h agoWhy students using social media 24X7 feel more isolated than ever beforesentinelassam.com · India